長庚大學癌症精準治療小考

長庚大學癌症精準治療小考

University

10 Qs

quiz-placeholder

Similar activities

enzymes practice quiz (lecture 1 to 4)

enzymes practice quiz (lecture 1 to 4)

University

13 Qs

人類發展學 L9 選擇題

人類發展學 L9 選擇題

University

10 Qs

S&MphaseEntry2

S&MphaseEntry2

University

15 Qs

Practice Questions_Biochem of Signaling

Practice Questions_Biochem of Signaling

University

15 Qs

Lec 10, 11, 12; ETC, REVIEW & Gluconeogenesis

Lec 10, 11, 12; ETC, REVIEW & Gluconeogenesis

University

10 Qs

Cell cycle control

Cell cycle control

11th Grade - University

14 Qs

Cell Cycle 09.30

Cell Cycle 09.30

University

15 Qs

泌尿系統小測驗

泌尿系統小測驗

University

10 Qs

長庚大學癌症精準治療小考

長庚大學癌症精準治療小考

Assessment

Quiz

Biology

University

Easy

Created by

tracy chen

Used 5+ times

FREE Resource

AI

Enhance your content

Add similar questions
Adjust reading levels
Convert to real-world scenario
Translate activity
More...

10 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

關於癌症精準治療標的,下列何者非小分子抑制劑作用位點?

EGFR Kinase

HER2 Kinase

Proteasome

Immune Checkpoint

2.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

下列哪一個藥品作用位點不是BCR-ABL tyrosine kinase?

Imatinib

Nilotinib

Dasatinib

Erlotinib

3.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

下列哪一個小分子抑制劑是HER2 Kinase Inhibitors,主要用於乳癌治療?

Trastuzumab

Pertuzumab

Lapatinib

Erlotinib

4.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

下列哪一個藥品不是VEGFR/PDGFR Kinase Inhibitors?

Pazopanib

Sunitinib

Sorafenib

Vemurafenib

5.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

下列哪一個小分子抑制劑是Alk Inhibitors,主要用於肺癌治療?

Brigatinib

Osimertinib

Gefitinib

Erlotinib

6.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

下面哪一個Monoclonal Antibody是EGFR Kinase Inhibitors?

Cetuximab

Olaratumab

Trastuzumab

Pertuzumab

7.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

下面哪一個Monoclonal Antibody是VEGFR Kinase Inhibitors?

Cetuximab

Bevacizumab

  Trastuzumab

Pertuzumab

Create a free account and access millions of resources

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

By signing up, you agree to our Terms of Service & Privacy Policy

Already have an account?